Collection 3 (Sep 2022 - Aug 2023) Articles

Articles
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)
Shaik A, Kosiborod M, de Lemos JA, et al.
Journal:
Clin Cardiol

First published: September 19, 2022 DOI: 10.1002/clc.23923
View
- Share
Articles
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
Patti G, Spinoni EG, Grisafi L, et al.
Journal:
Eur Heart J Cardiovasc Pharmacother

First published: September 14, 2022 DOI: 10.1093/ehjcvp/pvac049
View
- Share
Articles
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Warden BA, Guyton JR, Kovacs AC, et al.
Journal:
J Clin Lipidol

First published: September 11, 2022 DOI: 10.1016/j.jacl.2022.09.001
View
- Share
Articles
Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
Kuan PX, Chan WK, Fern Ying DK, et al.
Journal:
Lancet Digit Health

First published: September 1, 2022 DOI: 10.1016/S2589-7500(22)00124-8
View
- Share

1 … 6 7 8